Published in
Dove Press, Therapeutics and Clinical Risk Management, (Volume 13), p. 871-879
DOI: 10.2147/tcrm.s134398
Links
Tools
Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 